OGG1 protein suppresses G:C→T:A mutation in a shuttle vector containing 8-hydroxyguanine in human cellsSUNAGA, Noriaki; KOHNO, Takashi; SHINMURA, Kazuya et al.Carcinogenesis (New York. Print). 2001, Vol 22, Num 9, pp 1355-1362, issn 0143-3334Article

Epigenetic inactivation of the RUNX3 gene in lung cancerSATO, Koji; TOMIZAWA, Yoshio; IUIMA, Hironobu et al.Oncology reports. 2006, Vol 15, Num 1, pp 129-135, issn 1021-335X, 7 p.Article

Over-expression of p27^kip1 induces growth arrest and apoptosis mediated by changes of pRb expression in lung cancer cell linesNARUSE, Ichiro; HOSHINO, Hideki; DOBASHI, Kunio et al.International journal of cancer. 2000, Vol 88, Num 3, pp 377-383, issn 0020-7136Article

Clinicopathologic significance of the mutations of the Epidermal Growth Factor Receptor gene in patients with non-small cell lung cancerTOMIZAWA, Yoshio; IIJIMA, Hironobu; DOBASHI, Kunio et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 6816-6822, issn 1078-0432, 7 p., 1Article

Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markersYANAGITANI, Noriko; KOHNO, Takashi; KIM, Jeong-Gyoon et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 4, pp 366-371, issn 1055-9965, 6 p.Article

Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinomaTOMIZAWA, Yoshio; KOHNO, Takashi; MINNA, John D et al.Clinical cancer research. 2002, Vol 8, Num 7, pp 2362-2368, issn 1078-0432Article

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancerKAIRA, Kyoichi; SUNAGA, Noriaki; YOSHII, Akihiro et al.Lung cancer. 2010, Vol 69, Num 1, pp 99-104, issn 0169-5002, 6 p.Article

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancerKAIRA, Kyoichi; SUNAGA, Noriaki; HISADA, Takeshi et al.Lung cancer. 2010, Vol 68, Num 2, pp 253-257, issn 0169-5002, 5 p.Article

Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapySUNAGA, Noriaki; TOMIZAWA, Yoshio; SAITO, Ryusei et al.Lung cancer. 2007, Vol 56, Num 3, pp 383-389, issn 0169-5002, 7 p.Article

Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapyTOMIZAWA, Yoshio; FUJITA, Yuka; TAMURA, Atsuhisa et al.Lung cancer. 2010, Vol 68, Num 2, pp 269-272, issn 0169-5002, 4 p.Article

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancersKAIRA, Kyoichi; SUNAGA, Noriaki; TOMIZAWA, Yoshio et al.International journal of oncology. 2007, Vol 31, Num 1, pp 169-173, issn 1019-6439, 5 p.Article

Association of polymorphisms in the MTH1 gene with small cell lung carcinoma riskKOHNO, Takashi; SAKIYAMA, Tokuki; SASAKI-MATSUMURA, Rumie et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 12, pp 2448-2454, issn 0143-3334, 7 p.Article

Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus VinorelbineIMAI, Hisao; SHUKUYA, Takehito; MURAKAMI, Haruyasu et al.Chemotherapy (Basel). 2013, Vol 59, Num 4, pp 307-313, issn 0009-3157, 7 p.Article

Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REVI and LIG4 with lung cancer riskSAKIYAMA, Tokuki; KOHNO, Takashi; KIMURA, Junko et al.International journal of cancer. 2005, Vol 114, Num 5, pp 730-737, issn 0020-7136, 8 p.Article

Effect of nebulized furosemide in terminally ill cancer patients with dyspneaKOHARA, Hiroyuki; UEOKA, Hiroshi; AOE, Keisuke et al.Journal of pain and symptom management. 2003, Vol 26, Num 4, pp 962-967, issn 0885-3924, 6 p.Article

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancerKAIRA, Kyoichi; TOMIZAWA, Yoshio; SATO, Koji et al.Lung cancer. 2013, Vol 82, Num 1, pp 103-108, issn 0169-5002, 6 p.Article

A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancerKAWAGUCHI, Tomoya; TAKADA, Minoru; SAITO, Ryusei et al.European journal of cancer (1990). 2012, Vol 48, Num 5, pp 672-677, issn 0959-8049, 6 p.Article

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypesKOHNO, Takashi; KUNITOH, Hideo; HIROSE, Hiroshi et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 5, pp 834-841, issn 0143-3334, 8 p.Article

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibilitySUNAGA, Noriaki; KOHNO, Takashi; YANAGITANI, Noriko et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 8, pp 730-738, issn 1055-9965Article

Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma riskKOHNO, Takashi; KUNITOH, Hideo; TOYAMA, Kaoru et al.Cancer science. 2006, Vol 97, Num 8, pp 724-728, issn 1347-9032, 5 p.Article

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancersIIJIMA, Hironobu; TOMIZAWA, Yoshio; IWASAKI, Yasuki et al.International journal of cancer. 2006, Vol 118, Num 4, pp 797-801, issn 0020-7136, 5 p.Article

Clinicopathological significance of aberrant methylation of RARβ2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancerTOMIZAWA, Yoshio; IIJIMA, Hironobu; NOMOTO, Taisuke et al.Lung cancer. 2004, Vol 46, Num 3, pp 305-312, issn 0169-5002, 8 p.Article

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1YANAGITANI, Noriko; KOHNO, Takashi; SUNAGA, Noriaki et al.Carcinogenesis (New York. Print). 2002, Vol 23, Num 7, pp 1177-1183, issn 0143-3334Article